Future Mortality Risk Measured by Life Expectancy in Various Cancers

Share this content:
Life expectancy is a significant indicator of future mortality risk and additional care in patients with cancer of the breast, colon and testes.
Life expectancy is a significant indicator of future mortality risk and additional care in patients with cancer of the breast, colon and testes.

Life expectancy is a significant indicator of future mortality risk and additional care in patients with cancer of the breast, colon and testes, according to a recent study published in Annals of Oncology.

Italian researchers led by Riccardo Capocaccia, MSc, of the Foundation National Cancer Institute in Milan evaluated SEER registry data of patients diagnosed with these cancers from 1985 to 2011 in relation to mortality data of the general U.S. population.

They found that life expectancy steadily increases in patients with colon cancer who survive the first four years after diagnosis, and then begins to decrease once more to that of the general population. Younger patients demonstrated wider differences in life expectancy compared to the general population.

RELATED: Life Expectancy Further Reduced By Each Chronic Condition

In patients with breast cancer, life expectancy still decreased steadily after diagnosis, but less than in the general population, approaching that of women who were cancer-free.

The researchers noted that life expectancy of men with testicular cancer at 30 years of age is estimated at 45.2 years, which is two years less than cancer-free men of the same age. The difference, therefore, becomes 1.3 years for patients who survive the first year, approaching zero as time progresses.

“Life expectancy provide meaningful information on cancer patients, and can help in assessing when a cancer survivor can be considered as cured,” the authors concluded.

Reference

  1. Capocaccia, Riccardo, et al. "Life expectancy of colon, breast, and testicular cancer patients. An analysis of US-SEER population-based data." Annals of Oncology. doi: 10.1093/annonc/mdv131. March 3, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters